Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ACUTAAS.NS
BuyPremium GrowerAcutaas Chemicals Limited · Basic Materials · India · $2.7B · Avg Vol: $10M/d
COMPANY DESCRIPTION
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
FINANCIAL SUMMARY (INR)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.1B | 7.1B | 10.0B | 13.3B | 29.4% | 14.7B | 17.6B | 23.0B | 31.7% |
| EPS (INR) | 11.43 | 5.83 | 19.81 | 43.51 | 56.1% | 47.26 | 56.35 | 72.19 | 28.8% |
| Shares | 72.9M | 73.8M | 81.9M | 81.9M | +12.3% | 81.9M | — | — | — |
| Debt | 36.0M | 2.2B | 129.4M | 356.0M | 114.6% | 357.2M | — | — | — |
| Equity | 5.9B | 6.7B | 13.1B | 16.5B | 40.7% | — | — | — | — |
| Op CF | 655.3M | 1.3B | 1.2B | 2.9B | 64.6% | 2.9B | — | — | — |
| Inv CF | -330.4M | -3.7B | -2.2B | -2.7B | — | — | — | — | — |
| Fin CF | -122.5M | 2.4B | 2.6B | 41.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Basic Materials, ranked by industry match, size, and score similarity. Cross-listings of ACUTAAS.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ACUTAAS.NS | Acutaas Chemicals Limited(you) | $2.7B | 65 | Buy |
| AETHER.NS | Aether Industries Limited | $2.3B | 60 | Hold |
| AARTIIND.NS | Aarti Industries Limited | $1.9B | 60 | Hold |
| SPLPETRO.NS | Supreme Petrochem Limited | $1.6B | 67 | Buy |
| BASF.NS | BASF India Limited | $1.7B | 69 | Buy |
| HSCL.NS | Himadri Speciality Chemical Limited | $3.6B | 56 | Hold |
| VINATIORGA.NS | Vinati Organics Limited | $1.5B | 62 | Hold |
| BERGEPAINT.NS | Berger Paints India Limited | $5.9B | 64 | Hold |
| GRWRHITECH.NS | Garware Hi-Tech Films Limited | $1.7B | 72 | Buy |
| FINEORG.NS | Fine Organic Industries Limited | $1.7B | 73 | Buy |
Peer medians: ROE 10.1% · P/E 24.3x · Gross margin 38.4%